Skip to Main Content

Paper Details

Dapagliflozin and Physical and Social Activity Limitations in Heart Failure With Reduced Ejection Fraction.
JACC Heart Fail
1
2023
Cardiomyopathy, Cardiovascular Death, Chronic Heart Failure, DAPA, Dapagliflozin, HF, HFrEF, Heart Failure, Heart failure, Patients, chronic diseases, dapagliflozin, patients
Author NameAffiliation
Mikhail KosiborodSaint Luke's Mid America Heart Institute, University of Missouri-Kansas City
Marc S SabatineBrigham and Women's Hospital
Marc S SabatineBrigham and Women's Hospital
  • 1 - 3

Datasets

Release 1.2